Bridging the Gap Between Knowledge and Health: The Epidemiologist as Accountable Health Advocate ("AHA!")

Epidemiology

Volumn 23, Issue 6, 2012, Pages 914-918

  Dowdy, David W ^a   Pai, Madhukar ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FUNDING; HEALTH PROMOTION; HUMAN; MEDICAL EDUCATION; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; PUBLICATION; SOCIETY;

CONSUMER ADVOCACY; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; PUBLICATIONS; SOCIAL RESPONSIBILITY;

EID: 84867539912     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182605843     Document Type: Article

References (50)

1. Centers for Disease Control and Prevention. Ten great public health achievements-united states, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:241-243.
2. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am J Public Health. 1996;86:678-683.
3. Gebbie KM. Who Will Keep the Public Healthy? Educating Public Health Professionals for the 21st Century. Washington, DC: National Academy Press; 2003.
4. Institute of Medicine. The Future of the Public's Health in the 21st Century. Washington, DC: National Academies Press; 2002.
5. Ness RB. Introduction. triumphs in epidemiology commentary. Ann Epidemiol. 2009;19:225.
6. Blair SN, Morris JN. Healthy hearts-and the universal benefits of being physically active: physical activity and health. Ann Epidemiol. 2009;19:253-256.
7. Oakley GP Jr. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology. Ann Epidemiol. 2009;19:226-230.
8. Brownson RC, Hartge P, Samet JM, Ness RB. From epidemiology to policy: toward more effective practice. Ann Epidemiol. 2010;20:409-411.
9. Mercer SL, Sleet DA, Elder RW, et al. Translating evidence into policy: lessons learned from the case of lowering the legal blood alcohol limit for drivers. Ann Epidemiol. 2010;20:412-420.
10. Widome R, Samet JM, Hiatt RA, et al. Science, prudence, and politics: the case of smoke-free indoor spaces. Ann Epidemiol. 2010;20:428-435.
11. Clements-Nolle K, Ballard-Reisch DS, Todd RL, Jenkins T. Nevada's academic-practice collaboration: public health preparedness possibilities outside an academic center. Public Health Rep. 2005;120(suppl 1):100-108.
12. Covich JR, Parker CL, White VA. The practice community meets the ivory tower: a health department/academic partnership to improve public health preparedness. Public Health Rep. 2005;120(suppl 1):84-90.
13. Morse SS. Building academic-practice partnerships: the center for public health preparedness at the Columbia university mailman school of public health, before and after 9/11. J Public Health Manag Pract. 2003;9:427-432.
14. Orfaly RA, Biddinger PD, Burstein JL, Leaning J. Integration of academia and practice in preparedness training: the Harvard school of public health experience. Public Health Rep. 2005;120(suppl 1):48-51.
15. Woolf SH. The meaning of translational research and why it matters commentary. JAMA. 2008;299:211-213.
16. Zerhouni E. The NIH roadmap. Science. 2003;302:63-72.
17. Minkler M, Blackwell AG, Thompson M, Tamir H. Community-based participatory research: implications for public health funding. Am J Public Health. 2003;93:1210-1213.
18. Sox HC, Greenfield S. Comparative effectiveness research: a report from the institute of medicine. Ann Intern Med. 2009;151:203-205.
19. U.S. Department of Health and Human Services. Advancing the Health, Safety, and Well-being of our People: FY 2012 President's Budget for Health and Human Services. Washington, DC: HHS; 2012.
20. Thielen L, Mahan CS, Vickery AR, Biesiadecki LA. Academic centers for public health preparedness: a giant step for practice in schools of public health. Public Health Rep. 2005;120(suppl 1):4-8.
21. Davis D, Evans M, Jadad A, et al. The case for knowledge translation: shortening the journey from evidence to effect. BMJ. 2003;327:33-35.
22. Elkin EB, Weinstein MC, Winer E P, et al. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2004;22:854-863.
23. Hoffmann-La Roche Ltd. Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancer. Available at: http://www.roche.com/med- cor-2010-01-28. Accessed March 3, 2012.
24. World Health Organization. Global Status Report on Road Safety. Geneva, Switzerland: World Health Organization; 2009.
25. Bolli R, Becker L, Gross G, et al. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res. 2004;95:125-134.
26. Gori GB. Presentation: epidemiology and public health: is a new paradigm needed or a new ethic? J Clin Epidemiol. 1998;51:637-641.
27. Gange SJ. Teaching epidemiologic methods. Epidemiology. 2008;19: 353-356.
28. Foxman B. Epidemiologists and public health policy. J Clin Epidemiol. 1989;42:1107-1109.
29. Rothman KJ, Poole C. Science and policy making. Am J Public Health. 1985;75:340-341.
30. Pearce N, McKinlay JB. Dissent: back to the future in epidemiology and public health: response to Dr. Gori commentary. J Clin Epidemiol. 1998;51:643-646; discussion 647-649.
31. Sandman PM. Emerging communication responsibilities of epidemiologists. J Clin Epidemiol. 1991;44(suppl 1):41S-50S.
32. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829-849.
33. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15-19.
34. Hanna JF. The scope and limits of scientific objectivity. Philos Sci. 2004;71:339-361.
35. Hart DM, Victor DG. Scientific elites and the making of US policy for climate change research, 1957-1974. Soc Stud Sci. 1993;23:643-680.
36. Tatsioni A, Bonitsis NG, Ioannidis J. Persistence of contradicted claims in the literature. JAMA. 2007;298:2517-2526.
37. Dowdy DW, Steingart KR, Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med. 2011;8:e1001074.
38. Young NS, Ioannidis JPA, Al-Ubaydli O. Why current publication practices may distort science. PLoS Med. 2008;5:e201.
39. Pielke RA. The Honest Broker: Making Sense of Science in Policy and Politics. Cambridge: Cambridge University Press; 2007.
40. Ioannidis J P. Why most published research findings are false. PLoS Med. 2005;2:e124.
41. Greenland S. Transparency and disclosure, neutrality and balance: shared values or just shared words? J Epidemiol Community Health. In press.
42. Bornstein D. How to Change the World: Social Entrepreneurs and the Power of New Ideas. New York, NY: Oxford University Press; 2007.
43. Gruen RL, Pearson SD, Brennan TA. Physician-citizens - public roles and professional obligations. JAMA. 2004;291:94-98.
44. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med. 2011;365:1025-1032.
45. Noelle-Neumann E. The Spiral of Silence: Public Opinion, our Social Skin. 2nd ed. Chicago, IL: University of Chicago Press; 1993.
46. Ness RB, Andrews EB, Gaudino JAJr, et al. The future of epidemiology. Acad Med. 2009;84:1631-1637.
47. Thacker SB, Dannenberg AL, Hamilton DH. Epidemic intelligence service of the centers for disease control and prevention: 50 years of training and service in applied epidemiology. Am J Epidemiol. 2001;154:985-992.
48. Moses H, Dorsey E, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294:1333-1342.
49. Wolin KY, Colditz GA, Proctor EK. Maximizing benefits for effective cancer survivorship programming: defning a dissemination and implementation plan. Oncologist. 2011;16:1189-1196.
50. Stephan P. How Economics Shapes Science. Boston, MA: Harvard University Press; 2012.